Coumarin can undergo hydroxylation at C3, C4, C6 and C7 apart
from at C5 and C8 positions (see inset of Fig. 15). The products
of C3, C4, C6 and C7 hydroxylation would not give a positive 4-
AAP test. The results indicate that the Y96F/T101V mutant of the
enzyme possibly produces 1.5 times more hydroxylation at C3, C4,
C6 and C7 positions compared to that at C5 and C8 of coumarin.
Thus the above results show that the engineering of the active site
of P450cam can be successfully exploited for the enhancement of
activity as well as regio-selectivity of hydroxylation of aromatic
compounds. However, it must be mentioned that the detailed and
quantitative characterization of the enzymatic properties of the
P450cam variants and the product distributions call for further
studies.
11 V. B. Urlacher, S. Lutz-Wahl and R. D. Schmid, Appl. Microbiol.
Biotechnol., 2004, 64, 317–325.
12 E. J. Mueller, P. J. Loida and S. G. Sligar, in Cytochrome P450: Structure,
Mechanism, and Biochemistry, ed. P. R. Oritz de Montellano, Plenum
Press, New York, 2nd edn, 1995, pp. 83-124.
13 M. R. Lefever and L. P. Wackett, Biochem. Biophys. Res. Commun.,
1994, 201, 373–378.
14 F. Xu, S. G. Bell, Z. Rao and L.-L. Wong, Protein Eng., Des. Sel., 2007,
20, 473–480.
15 C. F. Harford-Cross, A. B. Carmichael, F. K. Allan, P. A. England,
D. A. Rouch and L. L. Wong, Protein Eng., Des. Sel., 2000, 13, 121–
128.
16 R. J. Sowden, S. Yasmin, N. H. Rees, S. G. Bell and L. L. Wong, Org.
Biomol. Chem., 2005, 3, 57–64.
17 J. A. Stevenson, A. C. Westlake, C. Whittock and L.-L. Wong, J. Am.
Chem. Soc., 1996, 118, 12846–12847.
18 P. J. Jonathan, J. O. H. Ellen and W. Luet-Lok, Eur. J. Biochem., 2001,
268, 1460–1467.
19 S. G. Bell, X. Chen, F. Xu, Z. Rao and L. L. Wong, Biochem. Soc.
Trans., 2003, 31, 558–562.
Conclusions
20 S. G. Bell, X. Chen, R. J. Sowden, F. Xu, J. N. Williams, L.-L. Wong
and Z. Rao, J. Am. Chem. Soc., 2003, 125, 705–714.
21 D. P. Nickerson, C. F. Harford-Cross, S. R. Fulcher and L.-L. Wong,
FEBS Lett., 1997, 405, 153–156.
22 K. J. French, D. A. Rock, J. I. Manchester, B. M. Goldstein and J. P.
Jones, Arch. Biochem. Biophys., 2002, 398, 188–197.
23 V. Reipa, M. P. Mayhew, M. J. Holden and V. L. Vilker, Chem.
Commun., 2002, 318–319.
24 E. S. Ferreira, A. N. Hulme, H. McNab and A. Quye, Chem. Soc. Rev.,
2004, 33, 329–336.
25 H. Zollinger, in Color Chemistry: Syntheses, Propertiesand Applications
of Organic Dyes and Pigments, Wiley, 3rd edn, 2003, pp. 255-354.
26 R. Balamurugan, F. J. Dekker and H. Waldmann, Mol. BioSyst., 2005,
1, 36–45.
Our study showed that the protein engineering of cytochrome
P450cam can give a possible alternative route for the synthesis
of the industrially important blue dye indigo. It also showed that
the in vitro oxidative cycle is a cleaner method compared to the
reductive cycle as well as in vivo synthesis of the dye from indole.
The rational redesigning of the P450cam active site was found
to enhance the affinity of the enzyme for unnatural substrates as
well as the NADH oxidation rate in the presence of aromatic
compounds. The engineering of the P450cam active site was
found to enhance the activity of the enzyme for regio-selective
hydroxylation of coumarin. The present studies thus demonstrate
that the cytochrome P450cam can be successfully engineered for
synthetic as well as environmental applications.
27 N. Au and A. E. Rettie, Drug Metab. Rev., 2008, 40, 355–375.
28 P. H. Lee, S. K. Ong, J. Golchin and G. L. Nelson, Water Res., 2001,
35, 3941–3949.
29 K. M. Weir, T. D. Sutherland, I. Horne, R. J. Russell and J. G.
Oakeshott, Appl. Environ. Microbiol., 2006, 72, 3524–3530.
30 V. Y. Kuznetsov, E. Blair, P. J. Farmer, T. L. Poulos, A. Pifferitti and
I. F. Sevrioukova, J. Biol. Chem., 2005, 280, 16135–16142.
31 I. F. Sevrioukova and T. L. Poulos, J. Biol. Chem., 2002, 277, 25831–
25839.
32 R. A. Crowell, R. Lian, J. Sauer, M. C., D. A. Oulianov and I. A.
Shkrob, Chem. Phys. Lett., 2004, 383, 481–485.
33 E. Emerson, J. Org. Chem., 1943, 8, 417–428.
34 S. K. Manna and S. Mazumdar, Biochemistry, 2006, 45, 12715–12722.
35 B. Munge, C. Estavillo, J. B. Schenkman and J. F. Rusling, Chem-
BioChem, 2003, 4, 82–89.
Acknowledgements
The Authors wish to thank Mr. Bharat T. Kansara for help. This
work was supported by the Indo French Centre for the Promotion
of Advanced Research (IFCPAR/CEFIPRA), New Delhi. The
work was carried out at the Tata Institute of Fundamental
Research, Mumbai.
36 S. Jin, T. M. Makris, T. A. Bryson, S. G. Sligar and J. H. Dawson, J. Am.
Chem. Soc., 2003, 125, 3406–3407.
References
1 E. J. Corey and X.-M. Cheng, The Logic of Chemical Synthesis, Wiley,
New York, 1995.
37 H. Joo, A. Arisawa, Z. Lin and F. H. Arnold, Chem. Biol., 1999, 6,
699–706.
2 K. Godula and D. Sames, Science, 2006, 312, 67–72.
3 W.-M. Cheung, H.-Y. Ng, I. D. Williams and W.-H. Leung, Inorg.
Chem., 2008, 47, 4383–4391.
4 J. M. Keith, R. J. Nielsen, J. Oxgaard and W. A. Goddard, 3rd, J. Am.
Chem. Soc., 2005, 127, 13172–13179.
5 N. S. Loumbourdis, Bull. Environ. Contam. Toxicol., 1997, 58, 945–952.
6 J. O. Duruibe, M. O. C. Ogwuegbu and J. N. Egwurugwu, Int. J. Phys.
Sci., 2007, 2, 112–118.
38 J. L. Royo, E. Moreno-Ruiz, A. Cebolla and E. Santero, J. Biotechnol.,
2005, 116, 113–124.
39 A. Celik, R. E. Speight and N. J. Turner, Chem. Commun., 2005, 3652–
3654.
40 E. M. Gillam, A. M. Aguinaldo, L. M. Notley, D. Kim, R. G.
Mundkowski, A. A. Volkov, F. H. Arnold, P. Soucek, J. J. DeVoss
and F. P. Guengerich, Biochem. Biophys. Res. Commun., 1999, 265,
469–472.
7 T. Norseth, Environ. Health Perspect., 1981, 40, 121–130.
8 F. A. Carey and R. J. Sundberg, Part B: Reaction and Synthesis, 4th
edn, Kluwer Academic/Plenum Publishers, New York, 2001.
9 F. P. Guengerich, Chem. Res. Toxicol., 2001, 14, 611–650.
10 P. R. Oritz de Montellano and J. J. De Voss, in Cytochrome P450:
Structure, Mechanism, and Biochemistry, ed. P. R. Oritz de Montellano,
Plenum Press, New York, 3rd edn, 2005, pp. 183-246.
41 A. Singh, K. Chen, S. J. Adelstein and A. I. Kassis, Radiat. Res., 2007,
168, 233–242.
42 K. Nakamura, I. H. Hanna, H. Cai, Y. Nishimura, K. M. Williams and
F. P. Guengerich, Anal. Biochem., 2001, 292, 280–286.
43 B. Thati, A. Noble, B. S. Creaven, M. Walsh, M. McCann, K.
Kavanagh, M. Devereux and D. A. Egan, Cancer Lett., 2007, 248,
321–331.
This journal is
The Royal Society of Chemistry 2010
Dalton Trans., 2010, 39, 3115–3123 | 3123
©